Objective To retrospectively investigate the clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis. Methods We reviewed the medical records of 230 Japanese patients who had visited our hospital and been diagnosed with AL amyloidosis, and abstracted those with the systemic type. The clinical data at diagnosis of systemic AL amyloidosis, including laboratory and imaging findings, were analyzed. Results Two hundred and two patients (mean, 58.7±9.5 years) were enrolled in this study. Immunofixation or immunoelectrophoresis was performed in 173 patients, 144 of whom were positive for M-protein in the serum and/or urine (κ:λ=30:114). The primary clinical manifestations at diagnosis were proteinuria and/or renal dysfunction (54.0%), congestive heart failure (24.8%), peripheral neuropathy (10.4%), hepatomegaly (7.9%) and arrhythmia (5.0%). The remaining patients developed unusual manifestations, such as solitary tumor, lymphadenopathy, gastrointestinal bleeding, intestinal pseudoobstruction, hemorrhagic tendencies and polyarthralgia. Dilatation of the intestine with marked thickening of the gastrointestinal wall on computed tomography and multiple nodular lesions with associated mucosal friability on endoscopy are characteristic findings of systemic AL amyloidosis. Conclusion The clinical pictures of Japanese patients with systemic AL amyloidosis are similar to those previously reported from the US and European nations; however, some patients with this disease develop uncommon symptoms. Conducting laboratory and histological examinations for systemic AL amyloidosis is necessary when making a differential diagnosis of these symptoms.
Introduction
Amyloidosis refers to a group of disorders with a heterogeneous pathogenic background that are now classified into many subtypes according to the chemical nature of the primary constituent amyloid fibril proteins (1) . Amyloidosis derived from immunoglobulin light chains (AL) is a hematological disorder and a systemic form of the disease causes the dysfunction of multiple vital organs, including the heart, kidneys and gastrointestinal (GI) tract (2, 3) . Abnormal plasma cells in bone marrow play a central role in the motherapy regimens, including high-dose melphalan with autologous peripheral blood stem cell transplantation (HDM/ SCT) (9, 10) , have been performed in patients with primary systemic AL amyloidosis, resulting in significantly improved prognoses (11) . In order to achieve good therapeutic effects in patients with systemic AL amyloidosis, making a correct diagnosis at an early stage is necessary; therefore, paying further attention to the clinical picture of this disease is required.
In this report, we retrospectively studied the clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis who were diagnosed at our hospital, focusing on unusual symptoms and characteristic imaging findings.
Materials and Methods
We reviewed the medical records of 230 Japanese patients (127 men and 103 women; age range, 15 to 81 years; mean, 58.1±10.2 years) who had visited our hospital and been diagnosed with AL amyloidosis between April 2001 and December 2012. Two of the authors (M.M. and N.K.) abstracted the data regarding M-protein in the serum and urine determined using either immunofixation or immunoelectrophoresis, the histopathology of the biopsied tissues, including the gastroduodenal and rectal mucosa, skin, kidney, liver, endomyocardium and sural nerve and immunohistochemical analyses of the deposited amyloid fibril proteins using antibodies against four common different amyloid fibril proteins (12) and confirmed that all of the patients had suffered from AL amyloidosis. Demographic parameters, such as the age of onset and gender, and the number of visceral organs involved were abstracted simultaneously (13) . All of the patients who had shown AL amyloid deposits in multiple different organs or in even one organ with amyloidogenic M-protein in the serum and/or urine were enrolled in this study. We obtained further clinical information at diagnosis from the patients' medical records, such as the initial symptoms, serum albumin levels, renal and hepatic indices, presence of proteinuria, abnormal findings on electrocardiograms, echocardiographic data and results of imaging examinations, particularly computed tomography (CT). These data were expressed as the mean±standard deviation when necessary. Whether the patients had hepatic and/or renal dysfunction ascribable to the deposition of AL amyloid was evaluated according to the clinical criteria proposed by Gertz et al. (13) . The Committee for Medical Ethics of Shinshu University School of Medicine approved this study (No. 1,155).
Results
We found 202 patients to have systemic AL amyloidosis (121 men and 81 women; 28 to 81 years; mean, 58.7±9.5 years). All of these patients showed amyloid deposits in at least one biopsy site with some abnormal findings in laboratory data and/or radiological examinations suggestive of multiple organ involvement. Immunofixation or immunoelectrophoresis was performed in 173 patients, 144 of whom were positive for M-protein (κ:λ=30:114) in either the serum alone (n=15), urine alone (n=41) or both (n=88). Immunohistochemistry was performed on the biopsied tissues of 122 patients treated at our institute, and tissues of 38 and 82 patients were found to be positive for ALκ and ALλ, respectively. Two patients showed negative results on immunohistochemistry; however, microextraction and biochemical characterization identified their amyloid fibrils as being of immunoglobulin light-chain origin (14) . The remaining 80 patients whose biopsy samples were not available for our immunohistochemical analysis were considered to have systemic AL amyloidosis based on the presence of potassium permanganate-resistant amyloid deposits in the biopsied tissues with positive M-protein in the serum and/or urine (15) . Fourteen patients were classifiable as having the myelomaassociated type with regard to exhibiting 10% or higher plasma cells in the bone marrow according to the diagnostic criteria proposed by the International Myeloma Working Group (16) . Nevertheless, none of these 14 patients demonstrated any abnormal lesions suggestive of myeloma cell infiltration on either X-ray examinations or bone scintigraphy. Other myeloma-associated manifestations, such as anemia and a prominent increase in M-protein, were also unremarkable in these patients.
The age of onset and clinical manifestations at diagnosis in the 202 systemic AL amyloidosis patients are demonstrated in Fig. 1 . The disease developed most frequently in patients in their 60s; however, one and six patients showed the onset of symptoms in their 20s and 30s, respectively. Proteinuria and/or renal dysfunction (n=109, 54.0%) was the most common manifestation, and 90 patients fulfilled the criteria for nephrotic syndrome. Congestive heart failure (n= 50, 24.8%) was the second most common comorbidity. Data for echocardiograms were available in 36 of the 50 patients, and the thickness of the interventricular septum, percent fractional shortening (%FS) and E-wave deceleration time (DT) were 16.2±3.1 mm (normal <12 mm), 28.2±7.6% (normal >28%) and 145.2±38.7 ms (normal 180-250 ms), respectively. Ten patients underwent scintigraphy using 99m technetium-pyrophosphate, which is sensitive for cardiac amyloidosis (17) ; however, only five showed a positive uptake. The third most frequent manifestation was peripheral neuropathy (n=21, 10.4%), including somatic and autonomic nerve dysfunction and carpal tunnel syndrome. Four patients exhibited bilateral carpal tunnel syndrome without obvious polyneuropathy, three of whom also had other organ involvement, such as congestive heart failure. The fourth most frequent manifestation was hepatomegaly with or without liver dysfunction (n=16, 7.9%). Fourteen patients displayed marked increases in the levels of alkaline phosphatase (Fig. 2) . Arrhythmia, such as sick sinus syndrome, was the fifth most common manifestation (n=10, 5.0%), and three patients experienced Stokes-Adams attacks due to marked bradycardia. The remaining patients developed the following unusual manifestations:
Solitary tumor
Eight patients exhibited solitary tumors, so-called amyloidomas. The sites of the amyloidomas included the lungs, stomach, urinary bladder, prostate, rectum, tongue, epipharynx and anterior mediastinum in one patient each. The deposited amyloid was ALλ in six patients and ALκ in two patients. Two patients with amyloidomas in either the urinary bladder or rectum manifested recurrent bleeding, such as gross hematuria and/or melena ( Fig. 3A ) and one patient with a prostate amyloidoma suffered from dysuria (18), while the remaining five patients happened to notice tumors themselves or were found to have tumors on annual health screenings without demonstrating clinical symptoms. The amyloidomas showed nodular expansion with or without protrusion from the circumferential mucosa characterized histologically by massive amyloid deposition with no evidence of associated malignancy except for those observed in either the stomach or lungs. The gross appearance of the gastric amyloidoma revealed an irregularly-shaped small lesion slightly depressed from the circumferential mucosa that resembled early-stage carcinoma classifiable as type IIc (Fig. 3B ). Histopathology demonstrated ALλ-positive amyloid deposition with no associated malignancies. In contrast, the lung amyloidoma in another patient contained a round nodule with marginal spicular formation on CT that was compatible with the radiological findings of malignancy, and the histopathology of the surgically removed tissue revealed ALλ-positive amyloid deposition around the adenocarcinoma. Immunohistochemistry revealed the tumor cells in this patient to be positive for cancer-associated surface antigens, such as receptors for advanced glycation endproducts (19) . All eight of the patients also showed amyloid deposition in the vascular walls in areas around the amyloidomas and other biopsied tissues, particularly the gastrointestinal mucosa and renal glomeruli.
Lymphadenopathy
Six patients manifested lymphadenopathy. Three of them exhibited an enlargement of several lymph nodes in localized areas, primarily in the cervical region, in addition to other symptoms ascribable to visceral organ involvement, such as nephrotic syndrome, while the remaining three patients demonstrated systemic lymphadenopathy alone. In the latter patients, swollen lymph nodes were seen in the cervical, axillar and inguinal regions and in the mediastinum as well as the retroperitoneum; some of these findings have been previously described (20, 21) . On physical examinations, these lymph nodes usually had a size of 1 to 3 cm in diameter, good mobility, a smooth surface, an elastic-firm consistency and no tenderness. As the lymph nodes adhered to the neighboring soft tissue in parallel with increases in size, their mobility was often decreased. The lymph nodes gradually became enlarged, some of which reached 4 cm or larger in diameter within several years. Nevertheless, no patients complained of any serious symptoms, such as dyspnea, even though the lymph nodes were enlarged on both sides of the neck (20) . CT often demonstrated a clear enhancement effect of the lymph nodes with or without calcification (Fig. 4) showing remarkable uptake in one patient on positron emission tomography ( PET ) using 18 Ffluorodeoxyglucose (FDG) (20) . Histopathology of the lymph nodes demonstrated massive deposition of amyloid with no obvious evidence suggestive of lymphoproliferative disorders (22) . On immunohistochemistry, these amyloid deposits were positive for ALλ and ALκ in four and two patients, respectively.
GI bleeding and intestinal pseudoobstruction
GI bleeding without solitary tumors and/or intestinal pseudoobstruction were observed in eight patients consisting of the former alone in three patients, the latter alone in three patients and both in two patients. Among those with GI 
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bleeding, three patients had tarry stools suggestive of upper GI tract bleeding (Fig. 5 ), while the remaining two patients manifested melena. All of the patients with intestinal pseudo-obstruction complained of abdominal distension and anorexia ascribable to decreased bowel motility. Abdominal CT demonstrated dilatation of the intestines, particularly from the duodenum to the ileum, and marked thickening of the GI wall sometimes with an air-fluid level (Fig. 6 ). Endoscopy revealed multiple nodular lesions and erosions often with associated mucosal friability, exhibiting easy bleeding against mechanical stimuli in the GI tract, particularly in the stomach and duodenum (Fig. 7A) . No lesions specific for bleeding were present. Histopathology of the biopsied mucosa demonstrated massive amyloid deposition frequently with infiltrations of plasma cells and lymphocytes indicative of polyclonality (Fig. 7B, C and D) . On immunohistochemistry these amyloid deposits were positive for ALλ and ALκ in five and three patients, respectively.
Hemorrhagic tendency
Two patients manifested a remarkable hemorrhagic tendency as the initial symptom. One patient developed massive hemorrhage in the peritoneal cavity after cholecystectomy with no obvious cause. Histopathology of the removed gallbladder and biopsied liver specimen demonstrated deposition of ALκ amyloid primarily on the vascular walls 
Polyarthralgia
Two patients manifested polyarthralgia. The biopsied tissue from the gastroduodenal mucosa showed ALλ amyloid deposition, leading to the diagnosis of AL amyloidosis in both patients (23) . One patient complained of bilateral gonalgia and cubitalgia, while the other exhibited symmetri-
Figure 6. CT in a patient with intestinal pseudo-obstruction demonstrating marked thickening of the wall in the stomach, particularly the distal portion (A), bulbus (B) and descending portion (C, arrow) of the duodenum and transverse colon (D).
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cal swelling with tenderness in multiple joints of the extremities, particularly the knees, shoulders, wrists and metacarpo-phalangeal and proximal interphalangeal joints. The physical findings in both patients resembled those of rheumatoid arthritis with regard to almost symmetrical involvement of multiple joints (Fig. 9 ). X-ray examinations revealed multiple irregularly-shaped areas of hyperlucency in the proximal epiphyses of the bilateral humeri and carpal bones, which coincided with low-intensity signals on both T1-and T2-weighted images of magnetic resonance imaging (MRI) (23) . Bone scintigraphy using technetium-99m methylene diphosphonate ( 99m Tc-MDP) demonstrated clear uptake in the swollen and tender joints (23) . In both patients, Creactive protein (CRP) was almost normal despite the presence of severe pain, and autoantibodies, including rheumatoid factor, anti-cyclic citrullinated peptide antibodies, antinuclear antibodies, and anti-neutrophil cytoplasmic antibodies, were all negative.
Discussion
Age at onset and common manifestations AL amyloidosis is the most common form among the five major types of systemic amyloidosis (24) ; the remaining four consist of amyloid A (AA), dialysis-related β2-microglobulin (Aβ2M), hereditary and senile systemic transthyretin-derived (ATTR) amyloidosis. According to a recent report, the estimated prevalence of AL amyloidosis in Japan is 6.1 per million persons (25) . In the present study of Japanese patients, systemic AL amyloidosis commonly affected people in their 50s or older, as previously shown in the USA (2); however, the disease can occur even patients in their 30s or younger. Proteinuria and/or renal dysfunction, including nephrotic syndrome, was the most frequent manifestation at diagnosis, followed by congestive heart failure. Approximately 80% of the patients manifested either or both of these two symptoms at diagnosis. The frequency of renal involvement at diagnosis was 28% in a previous report from the USA (2), compared to approximately 54% in the present study. This discrepancy may be in part due to the inclusion of patients with mild to moderate proteinuria in the present study in addition to those with nephrotic syndrome. Among the patients with congestive heart failure, the decrease in Ewave DT was more remarkable than that observed in %FS on echocardiograms, indicating that the diastolic function is more severely affected than the systolic function from the early phase of illness in patients with AL amyloid cardiomyopathy, as previously shown in several studies (26, 27) . Peripheral neuropathy, including carpal tunnel syndrome, is occasionally seen in patients with systemic AL amyloidosis and the clinical picture is known to be very similar to that observed in ATTR-type familial amyloid polyneuropathy with elderly onset (28, 29) . In the present study, there were no obvious relationships between clinical symptoms at diagnosis and either the type of deposited AL amyloid or circulating M-protein. Macroglossia, diffuse hard goiters and swelling of the salivary glands are well-known clinical 
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manifestations in patients with systemic AL amyloidosis (2, 3) ; however, the present study was unable to clarify the precise frequency of these symptoms.
Uncommon manifestations
The present study additionally found that some patients with this disease manifest unusual signs or symptoms at diagnosis, to which previous reports from the USA have paid little attention (2, 3) . Whether these manifestations are characteristic of Japanese or Asian patients with systemic AL amyloidosis should be clarified in further multinational investigations, and technical advances in techniques used at diagnosis, such as biopsies and immunohistochemistry, may in part contribute to the detection of such features. The first uncommon manifestation is solitary tumors, so-called amyloidomas, which are, in general, characterized grossly by mass formation in various organs and microscopically by heavy deposition of AL amyloid. This manifestation usually occurs in patients with the localized type (30, 31) and is infrequently associated with the systemic form of AL amyloidosis (32, 33) . In the localized form, amyloidogenic light chains are produced by local, tissue-based lymphoplasmacytic dyscrasia (34) (35) (36) , while in the systemic type, a circulating monoclonal protein functions as an amyloid precursor and amyloid deposition on the vascular walls in the affected organ is a characteristic finding (6) . M-protein in the serum and/or urine is therefore a potent clue to distinguish the systemic type from the localized type (37) . Considering that all of the 8 patients with amyloidoma in the present study also showed marked vascular wall involvement in the biopsied tissues with M-protein in the serum and/or urine (18, 19) , AL amyloid deposition may occur widely in visceral organs and severely in localized areas, leading to mass formation (38) , although the precise mechanisms remain unclear. Some antigens or proteins on the cell surface may play a role in inducing locally accelerated deposition of circulating amyloidogenic immunoglobulin light chains (19, 39) .
The second unusual sign is lymphadenopathy. Systemic amyloidosis affects lymph nodes in a frequency ranging from 17% to 37% (40) ; however, lymphadenopathy is rarely seen as an initial manifestation of this disease. As M-protein was present in the serum and/or urine with the clonal expansion of plasma cells or lymphoplasmacytoid cells in the bone marrow likely producing the precursor immunoglobulin, all of the patients with systemic lymphadenopathy alone in the present study were considered to be classifiable as having systemic AL amyloidosis, although three of them showed no clear evidence suggestive of visceral organ involvement. The most characteristic finding was that amyloid deposition developed primarily in the lymph nodes, particularly in the cervical and supraclavicular regions. In some patients, CT demonstrated a clear enhancement effect of the lymph nodes, as observed in malignant lymphomas. These findings are ascribable to damage to vascular walls caused by amyloid deposition. One patient also showed a positive result on FDG-PET (20) . Massive deposition of amyloid may have induced the activation of lymphocytes, resulting in marked uptake of FDG.
The third uncommon manifestation is GI bleeding and intestinal pseudo-obstruction. As systemic AL amyloidosis often affects the GI tract from the early phase of illness even without clinical symptoms, the upper and/or lower portions are selected as a preferential site for biopsy when making a definitive diagnosis of this disease with regard to procedural safety and sensitivity (41) . Amyloid fibrils gradually accumulate in the GI wall and cause mucosal impairment leading to bleeding and intestinal pseudo-obstruction in parallel with a decrease in bowel motility via direct pressure of the neighboring tissues and/or ischemic changes due to vascular involvement (42, 43) . Endoscopically, mucosal polypoid lesions with friability and erosions are common findings (44, 45) . Due to the frequent involvement of the vascular walls, GI bleeding is more likely to occur in patients with systemic AL amyloidosis than in those with the localized form (31, 45) . Abdominal CT sometimes shows thickening and dilatation of the GI tract with soft tissue infiltration (46) . When either or both findings of GI bleeding and intestinal pseudo-obstruction are present, the CT findings of a thickened GI wall, as observed in the present study, is an important clue for the diagnosis of systemic or GI localized AL amyloidosis.
The fourth uncommon manifestation is a hemorrhagic tendency. Skin petechiae are a usual manifestation of systemic AL amyloidosis, particularly in the advanced stage; however, massive subcutaneous hemorrhage or hematoma formation as observed in the present study is very rare at diagnosis. This clinical picture resembles that of hemophilia. Recurrent submucosal hematomas in the gastrointestinal tract have also been reported in a patient with systemic AL amyloidosis (44) . According to several recent reports, acquired hemostatic abnormalities, including coagulation factor deficiencies, hyperfibrinolysis and platelet dysfunction, can occasionally cause massive bleeding in patients with systemic AL amyloidosis (47, 48) ; however, the pathological findings observed in the present study suggest that a hemorrhagic tendency is also ascribable to increased fragility and impaired vasoconstriction of the vessels affected by amyloid deposition. Systemic AL amyloidosis should actively be considered as a possible diagnosis in elderly patients with an acquired hemorrhagic tendency without abnormalities in platelets or coagulation factors.
The fifth unusual sign is polyarthralgia. Among the types of amyloidosis, arthropathy preferentially occurs in patients with the β2M-derived type, which complicates chronic renal failure requiring hemodialysis (49, 50) . Amyloid deposition develops in the bone and synovial membrane, leading to polyarthralgia and swelling due to destructive arthropathy (49, 50) . This type of arthropathy can also occur in patients with AL (2, 51, 52). One patient in the present study exhibited symmetrical swelling of both shoulders, the socalled 'shoulder-pad sign,' and a limited range of motion in multiple joints from the early phase of illness (23) . To detect amyloid deposition in joints, MRI and scintigraphy are useful (50, 53) . In this patient, an X-ray of the bones demonstrated multiple areas of hyperlucency in the epiphyseal regions, which coincided with low-intensity signals on both T1-and T2-weighted images of MRI (23) . Multiple myeloma usually demonstrates low-and high-intensity signals on T1-and T2-weighted images of MRI, respectively, while amyloid deposition in the bone is depicted as lowintensity signals on both types of images (50, 54, 55) . Diphosphonate has a high affinity for amyloid fibrils, irrespective of precursor proteins (53, 56, 57) , and bone scintigraphy using 99m Tc-MDP demonstrates obvious uptake only around swollen joints (23) . These radiographical findings suggest that deposition of amyloid in the bone and synovial membrane may have caused the polyarthralgia and swelling of the joints observed in the present patient.
In conclusion, systemic AL amyloidosis occasionally presents with more varieties of clinical symptoms than previously thought. The use of endoscopy with histopathological examinations, measurements of M-protein in both the serum and urine and a whole-body survey, including CT, should be actively considered as early as possible in order to make a definitive diagnosis of systemic AL amyloidosis, as the disease is recently becoming treatable in conjunction with the clinical use of intensive chemotherapy regimens targeting pathogenic plasma cells, such as HDM/SCT, dexamethasone and bortezomib (9, 10) .
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